Cargando…
Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information
Crohn's disease (CD) and ulcerative colitis (UC) are two etiologically related yet distinctive subtypes of the inflammatory bowel diseases (IBD). Differentiating CD from UC can be challenging using conventional clinical approaches in a subset of patients. We designed and evaluated a novel molec...
Autores principales: | Liu, Ruize, Li, Dalin, Haritunians, Talin, Ruan, Yunfeng, Daly, Mark J., Huang, Hailiang, McGovern, Dermot P.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568094/ https://www.ncbi.nlm.nih.gov/pubmed/37841595 http://dx.doi.org/10.1016/j.isci.2023.108053 |
Ejemplares similares
-
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017) -
Association of NOD2 and IL23R with Inflammatory Bowel Disease in Puerto Rico
por: Ballester, Veroushka, et al.
Publicado: (2014) -
Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease
por: Potdar, Alka A., et al.
Publicado: (2021) -
Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease
por: Potdar, Alka A., et al.
Publicado: (2020) -
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
por: Li, Dalin, et al.
Publicado: (2021)